Epilepsy in patients with Cornelia de Lange syndrome: A clinical series |
| |
| Authors: | Alberto Verrotti Sergio Agostinelli Giovanni Prezioso Giangennaro Coppola Giuseppe Capovilla Antonino Romeo Pasquale Striano Pasquale Parisi Salvatore Grosso Alberto Spalice Thomas Foiadelli Paolo Curatolo Francesco Chiarelli Salvatore Savasta |
| |
| Affiliation: | 1. Department of Pediatrics, University of Chieti, Chieti, Italy;2. Department of Child Neuropsychiatry, Second University of Salerno, Salerno, Italy;3. Department of Child Neuropsychiatry, Carlo Poma Hospital, Mantua, Italy;4. Child Neuropsychiatry and Neurophysiology, Epilepsy Center “Fatebenefratelli e Oftalmico” Hospital, Milano, Italy;5. Muscular and Neurodegenerative Diseases Unit, “G. Gaslini” Institute, University of Genova, Genova, Italy;6. Child Neurology, Chair of Pediatrics, II Faculty of Medicine, “La Sapienza” University, Rome, Italy;7. Department of Pediatrics, University of Siena, Siena, Italy;8. Department of Pediatrics, University of Rome “La Sapienza”, Rome, Italy;9. Department of Pediatrics, University of Pavia, Pavia, Italy;10. Department of Neurosciences, Pediatric Neurology Unit, Tor Vergata University, Rome, Italy |
| |
| Abstract: | PurposeCornelia de Lange (CdLS) syndrome is characterized by multiple congenital anomalies and mental retardation. Epilepsy is a clinical feature found in about 20% of cases, but there are no data about its electroclinical features and long-term outcome.Methodswe describe a clinical series of fourteen Caucasian CdLS paediatric patients who developed epilepsy, with special reference to the long term prognosis.ResultsEpilepsy manifested between age 0.6 and 16.3 years. The majority of patients (64.3%) presented with partial seizures and interictal EEGs mainly revealed focal epileptic paroxysms involving temporal and parietal areas. Thirteen of 14 children became seizure-free with treatment. Valproate monotherapy was used in eight patients (57.1%), controlling seizures in seven. Otherwise monotherapy with topiramate, levetiracetam, carbamazepine and oxcarbazepine appeared to be effective in controlling seizures in four cases. At the end of the follow-up (age range, 7.3–24.2 years; follow-up, 8.2 ± 3.9 years), thirteen patients were seizure free (three still in therapy), while in one patient seizures were not controlled.ConclusionsPartial epilepsy is the most common type of epilepsy in CdLS patients. In the majority of cases the prognosis of this epilepsy is favourable and therapy can be withdrawn after few years of complete seizure control. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
